Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider

Diabetes Care. 2006 Aug;29(8):1990-1. doi: 10.2337/dc06-0997.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / mortality*
  • Humans
  • Insulin / therapeutic use*
  • Neoplasms / complications
  • Neoplasms / drug therapy*
  • Neoplasms / mortality*
  • Sulfonylurea Compounds / therapeutic use*

Substances

  • Insulin
  • Sulfonylurea Compounds